FODZYME
Enzymes for dietary triggers
Kiwi Biosciences develops novel enzymes that break down common digestive triggers in food, so people with IBS can enjoy a normal meal.
- Founders
- Anjie Liu, David Hachuel Gurska
- YC batch
- S21
- Also known as
- Kiwi Biosciences
Company posts
Summaries from the company’s own website.
- FOOD: The Main Course 2026 takeaways ↗
The post shares a dietitian’s takeaways from the FOOD: The Main Course 2026 conference on GI nutrition and care. It reviews updates on Rome V, IBS and the microbiome, flexible FODMAP approaches, IBD and EoE diet strategies, constipation guidance, hormone-related GI changes, eating disorder screening, vagus nerve therapies, complementary treatments, and culturally inclusive nutrition care.
- Targeting Fermentation Load as a Strategy for Post-Infectious Gut Urgency: A Role for FODZYME® ↗
The post argues that post-infectious gut urgency may persist after gastroenteritis or traveler’s diarrhea because infection- or antibiotic-related dysbiosis can alter motility and fermentation. It hypothesizes that FODZYME® could help by breaking down fructans, GOS, and lactose before they reach the colon, reducing fermentable load, gas, and osmotic effects during recovery.